Anxiety of Patient and His Partner During Admission to Emergency Department (ANXURG)

August 30, 2017 updated by: University Hospital, Toulouse
Evaluate and compare the impact of partner's stress in the pain of the patient admitted in the emergency department

Study Overview

Detailed Description

Admission to an emergency department is a major source of anxiety for the patient. Anxiety plays not only a role in its emotional state but can also have consequences on the taking care of the patient and especially on the analgesic procedure.

Since pain is one of the first causes of emergency admission, patient anxiety should not be overlooked. In the emergency department, patient consults frequently, with his partner . Anxiety can also affect the partner, which may affect the patient. No studies have yet demonstrated this correlation.

This study will evaluate, the anxiety of both parties and show the presence or not of an influence of the partner's anxiety on the patient using a standardized questionnaire, the State-Trait Anxiety Inventory- form Y (STAI-Y).

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France, 31000
        • University Hospital of Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

people admited in the emergency department and his partner

Description

Inclusion Criteria:

  • Admission to emergency department accompanied by his partner (lives in concubinage with the patient)
  • Nurse patient's classification score up or equal to 3, 4 or 5
  • Oral consent given to the inclusion by the patient and the partner
  • Patient and partner Francophone or with a good understanding of French

Exclusion Criteria:

  • Patient under a system of legal protection
  • Non-Communicating Patient and partner
  • Patient and partner unable to write
  • Refusal of patient or partner
  • Admission of the patient with shock treatment corresponding to the nurse patient's classification score 1 and 2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
hospitalized patient
100 patients will completed the 'State-Trait-Anxiety Inventory (Forme Y) questionnaire Patients will evaluated here pain answering to a pain level scale
after admission in the emergency department, patient and his partner will completed STAI Y questionnaire.
as usual caregiver will ask to the patient to evaluated his pain level with a scale of one to ten
partner of the hospitalized patient
100 partners will completed the State-Trait-Anxiety Inventory (Forme Y) questionnaire
after admission in the emergency department, patient and his partner will completed STAI Y questionnaire.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare the anxiety of the patient with that of his partner
Time Frame: day 1
The anxiety will be evaluated by the State-Trait-Anxiety Inventory (Forme Y) questionnaire
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study the link between the patient's and his partner's anxiety
Time Frame: day 1
A corelation will be do between the score obtained by the patient and the score obtained by the partner at the STAI-Y questionnaire
day 1
Evaluate the link between the patient's anxiety and the patient's pain
Time Frame: day 1
The patient's pain will be evaluated orally asking to him to use a scale pain to 0 of 10
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vincent BOUNES, MD, University Hospital of Toulouse, Toulouse, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2017

Primary Completion (Actual)

July 6, 2017

Study Completion (Actual)

July 6, 2017

Study Registration Dates

First Submitted

July 27, 2017

First Submitted That Met QC Criteria

August 22, 2017

First Posted (Actual)

August 25, 2017

Study Record Updates

Last Update Posted (Actual)

August 31, 2017

Last Update Submitted That Met QC Criteria

August 30, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • RC31/17-0033
  • 2017-A00511-52 (Other Identifier: ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on State-Trait-Anxiety Inventory (Forme Y) questionnaire

Subscribe